Send mail to Author

Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis (Article)

Please indicate your contact information and select, which author you want to contact.



 
   _____     ___    __    __     ___     _    _      ___    
  / ___//   / _ \\  \ \\ / //   / _ \\  | |  | ||   / _ \\  
  \___ \\  / //\ \\  \ \/ //   | / \ || | |/\| ||  / //\ \\ 
  /    // |  ___  ||  \  //    | \_/ || |  /\  || |  ___  ||
 /____//  |_||  |_||   \//      \___//  |_// \_|| |_||  |_||
`-----`   `-`   `-`     `       `---`   `-`   `-` `-`   `-`
 


Back to frontdoor view

OPUS4 Logo